Your browser doesn't support javascript.
loading
Immune cell phenotypes associated with disease severity and long-term neutralizing antibody titers after natural dengue virus infection.
Rouers, Angeline; Chng, Melissa Hui Yen; Lee, Bernett; Rajapakse, Menaka P; Kaur, Kaval; Toh, Ying Xiu; Sathiakumar, Durgalakshmi; Loy, Thomas; Thein, Tun-Linn; Lim, Vanessa W X; Singhal, Amit; Yeo, Tsin Wen; Leo, Yee-Sin; Vora, Kalpit A; Casimiro, Danilo; Lim, Bing; Tucker-Kellogg, Lisa; Rivino, Laura; Newell, Evan W; Fink, Katja.
Affiliation
  • Rouers A; Singapore Immunology Network, Agency for Science, Technology and Research, Singapore 138648, Singapore.
  • Chng MHY; A∗STAR ID Labs, Agency for Science, Technology and Research, Singapore 138468, Singapore.
  • Lee B; Singapore Immunology Network, Agency for Science, Technology and Research, Singapore 138648, Singapore.
  • Rajapakse MP; Singapore Immunology Network, Agency for Science, Technology and Research, Singapore 138648, Singapore.
  • Kaur K; Singapore Immunology Network, Agency for Science, Technology and Research, Singapore 138648, Singapore.
  • Toh YX; Singapore Immunology Network, Agency for Science, Technology and Research, Singapore 138648, Singapore.
  • Sathiakumar D; Singapore Immunology Network, Agency for Science, Technology and Research, Singapore 138648, Singapore.
  • Loy T; Singapore Immunology Network, Agency for Science, Technology and Research, Singapore 138648, Singapore.
  • Thein TL; Singapore Immunology Network, Agency for Science, Technology and Research, Singapore 138648, Singapore.
  • Lim VWX; A∗STAR ID Labs, Agency for Science, Technology and Research, Singapore 138468, Singapore.
  • Singhal A; School of Biological Sciences, Nanyang Technological University, Singapore 637551, Singapore.
  • Yeo TW; National Centre for Infectious Diseases, Singapore 308442, Singapore.
  • Leo YS; National Centre for Infectious Diseases, Singapore 308442, Singapore.
  • Vora KA; Singapore Immunology Network, Agency for Science, Technology and Research, Singapore 138648, Singapore.
  • Casimiro D; A∗STAR ID Labs, Agency for Science, Technology and Research, Singapore 138468, Singapore.
  • Lim B; Lee Kong Chian School of Medicine, Singapore 308232, Singapore.
  • Tucker-Kellogg L; Lee Kong Chian School of Medicine, Singapore 308232, Singapore.
  • Rivino L; Tan Tock Seng Hospital, Singapore 308433, Singapore.
  • Newell EW; National Centre for Infectious Diseases, Singapore 308442, Singapore.
  • Fink K; Lee Kong Chian School of Medicine, Singapore 308232, Singapore.
Cell Rep Med ; 2(5): 100278, 2021 05 18.
Article de En | MEDLINE | ID: mdl-34095880
ABSTRACT
Prior immunological exposure to dengue virus can be both protective and disease-enhancing during subsequent infections with different dengue virus serotypes. We provide here a systematic, longitudinal analysis of B cell, T cell, and antibody responses in the same patients. Antibody responses as well as T and B cell activation differentiate primary from secondary responses. Hospitalization is associated with lower frequencies of activated, terminally differentiated T cells and higher percentages of effector memory CD4 T cells. Patients with more severe disease tend to have higher percentages of plasmablasts. This does not translate into long-term antibody titers, since neutralizing titers after 6 months correlate with percentages of specific memory B cells, but not with acute plasmablast activation. Overall, our unbiased analysis reveals associations between cellular profiles and disease severity, opening opportunities to study immunopathology in dengue disease and the potential predictive value of these parameters.
Sujet(s)
Mots clés

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Phénotype / Temps / Lymphocytes B / Anticorps neutralisants / Anticorps antiviraux Type d'étude: Risk_factors_studies Limites: Humans Langue: En Journal: Cell Rep Med Année: 2021 Type de document: Article Pays d'affiliation: Singapour

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Phénotype / Temps / Lymphocytes B / Anticorps neutralisants / Anticorps antiviraux Type d'étude: Risk_factors_studies Limites: Humans Langue: En Journal: Cell Rep Med Année: 2021 Type de document: Article Pays d'affiliation: Singapour